Biblio

Thompson EG, Shankar S, Gideon HP, Braun J, Valvo J, Skinner J, Aderem A, Flynn JAL, Lin PLing, Zak DE.  2018.  Blood RNA signatures prospectively discriminate controllers from progressors early after low-dose M. tuberculosis infection of cynomolgus macaques. :jiy006-jiy006.

Hansen SG, Zak DE, Xu G, Ford JC, Marshall EE, Malouli D, Gilbride RM, Hughes CM, Ventura AB, Ainslie E et al..  2018.  Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.. Nat Med. 24(2):130-143.

Thompson EG, Du Y, Malherbe ST, Shankar S, Braun J, Valvo J, Ronacher K, Tromp G, Tabb DL, Alland D et al..  2017.  Host blood RNA signatures predict the outcome of tuberculosis treatment.. Tuberculosis (Edinb). 107:48-58.

Scriba TJ, Penn-Nicholson A, Shankar S, Hraha T, Thompson EG, Sterling D, Nemes E, Darboe F, Suliman S, Amon LM et al..  2017.  Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.. PLoS Pathog. 13(11):e1006687.

Rothchild AC, Sissons JR, Shafiani S, Plaisier C, Min D, Mai D, Gilchrist M, Peschon J, Larson RP, Bergthaler A et al..  2016.  MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis.. Proc Natl Acad Sci U S A. 113(41):E6172-E6181.

Zak DE, Aderem A.  2015.  Systems integration of innate and adaptive immunity.. Vaccine. 33(40):5241-8.

Zak DE, Tam VC, Aderem A.  2014.  Systems-level analysis of innate immunity.. Annu Rev Immunol. 32:547-77.